Homerun Resources Inc. press release
Voyageur Pharmaceuticals' SmoothX abdominal diagnostic drink gets high praise in comparative study
TSXV - TSX Venture Exchange · Silicon · Gold · Copper · Silver · Antimony · Zinc · Iron · Diamond · Cobalt · Canada
(NewsDirect)
Voyageur Pharmaceuticals CEO Brent Willis joins Proactive's Natalie Stoberman to share the latest results from its SmoothX comparative studies.
Willis says results of the double-blind testing showed that SmoothX was favoured on drinkability and taste by 75% of patients compared to the competing product.
Before SmoothX goes to market, Willis adds a medical white paper is currently in preparation that will provide an in-depth analysis of the studies and insights into the effectiveness of SmoothX to educate and inform doctors and medical staff about the product's benefits for abdominal CT diagnostic imaging procedures.
Contact Details
Proactive Investors
+1 604-688-8158
na-editorial@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.
Earlier from Homerun Resources Inc.
- The Power Play by The Market Herald Releases New Interviews with Luminex Resources, Voyageur Pharmaceuticals, Trillion Energy, ARway and Pan Global Resources Discussing Their Latest News
- Voyageur Pharmaceuticals Ltd. Completes Comparative Studies of its SmoothX(R) Contrast Media Confirming Product Superiority, and announces Option Grant and AGM Date
- Voyageur Pharmaceuticals Ltd. Files Annual Audited Financial Statements